Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAXIMIN vs RIMABOTULINUMTOXINB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAXIMIN vs RIMABOTULINUMTOXINB: Safety Overview

Metric RIFAXIMIN RIMABOTULINUMTOXINB
Total FAERS Reports 13,861 176
Deaths Reported 5,009 38
Death Rate 36.1% 21.6%
Hospitalizations 4,847 35
Average Patient Age 63.2 yrs 59.0 yrs
% Female Patients 54.9% 68.6%
FDA Approval Date Mar 24, 2010 N/A
Manufacturer Salix Pharmaceuticals, Inc. Solstice Neurosciences, LLC
Route ORAL INTRAMUSCULAR
Marketing Status Prescription N/A